TEVA-DEXTROAMPHETAMINE SR
TEVA-DEXTROAMPHETAMINE SR
Approved
DIN Number
02448319
Drug Class
Human
Market Date
Oct 6, 2017
Company
HC
teva canada limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02448319
AIG Number0105933003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA I)
A
ATC Code
N06BA02 DEXAMFETAMINE
Product Specifications
Dosage FormCapsule (Sustained-Release)
Route of AdministrationOral
AHFS Classification28:20.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
DEXTROAMPHETAMINE SULFATEActive
Strength: 10 MG
Monograph: DEXTROAMPHETAMINE SULFATE